Business
Update. Re investor-led financing
Update. Re investor-led financing.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE \"UNITED STATES\"), AUSTRALIA, NEW ZEALAND, CANADA, JAPAN, THE REPUBLIC OF IRELAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION IS OR WOULD BE PROHIBITED.\n \nTHIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, ADVERTISING, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ONDINE BIOMEDICAL INC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF ONDINE BIOMEDICAL INC.\n \n \nOndine Biomedical Inc.\n(\"Ondine\" or the \"Company\")\n \nUpdate. Re investor-led financing\n \nOndine Biomedical Inc. (AIM: OBI), a Canadian life sciences company, announces that it has agreed to extend its Bookbuild process to midday on 4 December 2023, following indications of strong demand from Existing Shareholders to participate in its proposed Placing (as announced on 30 November 2023).\n \nFurther announcements will be made in due course.\n \nSave as otherwise defined, capitalised terms used in this announcement have the meanings given to them in the announcement released by the Company on 30 November 2023.\nEnquiries:\n\n\n\n\nOndine Biomedical Inc. \n\n\n \n\n\n\n\nAngelika Vance, Corporate Communications\n \n\n\n+001 (604) 838 2702\n\n\n\n\n \n\n\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser and Joint Broker)\n\n\n \n\n\n\n\nAubrey Powell, Asha Chotai, Sam Butcher\n \n\n\n+44 (0)20 7496 3000\n\n\n\n\n \n\n\n \n\n\n\n\nRBC Capital Markets (Joint Broker)\n\n\n \n\n\n\n\nRupert Walford, Kathryn Deegan\n \n\n\n+44 (0)20 7653 4000\n\n\n\n\n\n\n\n \n\n\n\n\nVane Percy & Roberts (Media Contact)\n\n\n\n\n\n\n\nSimon Vane Percy, Amanda Bern...